olfactory receptor family 11 subfamily H member 12Genealiases: []
Q-omics provides the consensus-scored OR11H12 profile across patient tissues and cancer cell-line models. OR11H12 expression is associated with patient survival in 6 of 34 cancer types, with the highest sampling consensus in KICH. Additionally, OR11H12 RNA expression shows 5,331 significant pathway-activity associations, with the highest sampling consensus in STAD. Together, these results highlight KICH, and STAD as cancer lineages where OR11H12 shows reproducible signals across survival, tumor–normal expression, and patient cross-omics analyses.
Every result is evaluated using two consensus scores. Sampling consensus measures how consistently a finding is reproduced within a cancer lineage across different conditions. Lineage consensus measures how broadly the result is shared across cancer types, distinguishing pan-cancer signals from lineage-specific patterns.
Premium analyses for OR11H12 — synthetic lethality, tumor antigen, and pembrolizumab response.
This table summarizes OR11H12 survival associations across molecular data types. OR11H12 RNA expression shows survival associations in the most cancer types (6), followed by mutation status (5). The rightmost column indicates the cancer type with the highest sampling consensus for each molecular layer.
This table ranks reproducible OR11H12 RNA expression–survival associations across cancer types. High OR11H12 expression shows unfavorable associations in KICH, ACC, STAD, SKCM and BRCA, but favorable associations in OV. The KICH Kaplan–Meier curve shows clear separation, with the high-expression group declining faster, consistent with the unfavorable association (log-rank p = .004). Together, the overview and detailed table identify KICH as the clearest survival context for OR11H12 RNA expression.
This table shows molecular features associated with OR11H12 in patient tissues and cancer cell lines. In patient samples, OR11H12 shows the broadest associations at the RNA and protein expression levels, with STAD recurring as the lineage with the largest associated feature set. In cancer cell lines, OR11H12 RNA and mutation anchors are most strongly linked to RNA-expression features, especially in BREAST, while CRISPR and shRNA rows add functional-dependency signals in LUNG_SCLC and LARGE_INTESTINE.
